Clinical Trials List
Protocol Number3129K4-3301-WW
2008-01-31 - 2014-12-31
Phase III
Terminated2
-
Trial Applicant
Wyeth-Ayerst (Asia) LLC
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Jyh-Pyng Gau Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
- 王緯書 Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- 余垣斌 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Su-Peng Yeh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
978 participants
